bpc-157 dosing guidelines protocol human BPC-157 Dosing (Common Protocols) πΉ Oral / Subcutaneous β’ 500 mcg daily β’ Duration: 6 weeks πΉ Intramuscular / Peritendinous β’ 1 mg daily β’ Duration: 6 weeks β οΈ Note: Not approved BPC-157 Dosage Guide: How Much
Description
PhaseOne also supplies GLOW, which extends this combination to include GHK-Cu for its copper-dependent mechanism, and KLOW, which adds KPV as a fourth component
Understanding each pathway helps explain why copper peptides show such promise for hair regrowth
Suganuma M, Saha A, Fujiki H
Molecules 18, 1080210828
Published research on GHK-Cu has linked it to tissue remodeling, collagen synthesis, fibroblast support, anti-inflammatory activity, and broader regenerative signaling
I am hoping to get shot 2, but a little worried if my immune system is revved up in an unhelpful way (I do have mild autoimmune stuff)
